| [1] |
FENG Yuxi, WANG Jinjin, CAI Yi, ZHU Runzhi, ZHU Qin.
Research Progress on Protein Lactylation in Kidney Diseases
[J]. Chinese General Practice, 2026, 29(21): 3056-3063.
|
| [2] |
HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian.
Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
[J]. Chinese General Practice, 2026, 29(21): 2950-2958.
|
| [3] |
PAN Ziyun, YIN Hao, LIN Zhirou, MAO Jingyi, HUANG Yan, LUO Yanhua, XIAO Jiafu, HU Yin.
From Mechanism to Therapy: Diabetic Autonomic Neuropathy
[J]. Chinese General Practice, 2026, 29(21): 2982-2988.
|
| [4] |
LIU Shuai, YUAN Shizhao, LIU Yan, JIA Shuoxian, ZHAO Yan, WANG Ziyi, ZHOU Chunhua, YU Jing.
Evaluation of the Efficacy, Safetyand Economy of Different Amphotericin B Formulationsin Invasive Fungal Disease: a Retrospective Cohort Study
[J]. Chinese General Practice, 2026, 29(21): 2967-2974.
|
| [5] |
LI Wenping, CHEN Jianhua, XU Jiapei, JIN Xue, PAN Zihan, CHI Chunhua.
A Scoping Review on the Empowerment of Community Elderly Health Services by Digital-Intelligent Health Management Platforms
[J]. Chinese General Practice, 2026, 29(21): 2938-2949.
|
| [6] |
YU Haiyan, XIANG Tong, GAO Wenjuan, WU Hao.
Research and Application of Digital Health Technologies in Multimorbidity Management
[J]. Chinese General Practice, 2026, 29(21): 2933-2937.
|
| [7] |
CHEN Dian, LONG Huanyu, CHU Lanhe, JIANG Yixia, GUO Wanjin, NIU Yang, CHEN Yahong.
Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2026 Report
[J]. Chinese General Practice, 2026, 29(21): 2913-2932.
|
| [8] |
ZHANG Zeyu, LI Chunhui.
Ischemic Heart Disease Burden Attributable to Second-hand Smoke in China from 1990 to 2021
[J]. Chinese General Practice, 2026, 29(20): 2903-2912.
|
| [9] |
WU Yixuan, XIAO Liangman, LIU Xin, YAN Ziqi, WANG Yuting, LIN Shumin, ZHUANG Lixing.
Analysis of the Disease Burden of Parkinson's Disease in China and Globally from 1990 to 2021 and Prediction of Future Trends
[J]. Chinese General Practice, 2026, 29(20): 2895-2902.
|
| [10] |
GE Dan, WANG Zhi, DING Qun, GUO Tonglan, XU Tongdao.
Relationship between Remnant Cholesterol and Non-alcoholic Fatty Liver Disease as well as Progressive Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2026, 29(20): 2854-2859.
|
| [11] |
REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan.
Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients
[J]. Chinese General Practice, 2026, 29(20): 2836-2845.
|
| [12] |
CHENG Yu, HAN Shiyao, SUN Ping, XIANG Juan, YANG Hui, LI Dongze, ZHENG Li, LIAO Xiaoyang.
Analysis of Socioeconomic and Demographic Challenges in Chronic Disease Management
[J]. Chinese General Practice, 2026, 29(20): 2800-2807.
|
| [13] |
LI Wanyu, JIN Hua, YANG Sen, FU Qiangqiang, YU Dehua.
Assessment and Optimization of Community Health Behaviors Guided by the Behaviour Change Wheel Theory
[J]. Chinese General Practice, 2026, 29(19): 2688-2694.
|
| [14] |
ZHANG Xiaojuan, LIU Yang, PENG Bo, YE Yuan, ZHU Kun.
Study on the Prevention and Treatment of Hypertension and Diabetes Mellitus in Community Hospital
[J]. Chinese General Practice, 2026, 29(19): 2614-2620.
|
| [15] |
ZHAO Huili, LU Lina, ZHUO Ya, WANG Xin.
Clinical Characteristics and Risk Factors for Recurrence of Cryptogenic Organizing Pneumonia
[J]. Chinese General Practice, 2026, 29(19): 2648-2655.
|